StonvexLoading…
StonvexCore line items from SAFX's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $348.69K | $20.82M | $16.13M | $6.58M |
Operating Income | $-10.34M | $-67.89M | $-48.91M | $-40.28M |
Net Income | $-17.81M | $74.00M | $90.29M | $102.80M |
EPS (Diluted) | $-0.07 | $0.52 | $0.69 | $0.84 |
Total Assets | $402.96M | $419.47M | $408.72M | $392.13M |
Total Liabilities | $377.65M | $381.82M | $403.51M | $380.05M |
Cash & Equivalents | $1.05M | $154.94K | $879.17K | $405.57K |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available |
Shares Outstanding | 290.95M | 206.47M | 149.26M | 149.26M |